acquired
Stage
About
Amicus Therapeutics is a wholly owned subsidiary of BioMarin Pharmaceutical Inc. focused on developing therapies for rare, genetically defined diseases.
Explore Amicus Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.